The data displays the global distribution of the cardiac biomarker market in 2016, by region. As of that year, the Americas were responsible for roughly half of the world's cardiac biomarker market.
Americas | 49.6 |
Europe, the Middle East and Africa | 31.7 |
Asia-Pacific | 18.7 |